3,5-Dibromo-2-(2,4-dibromophenoxy)phenol


Curated chemical-phenotype interactions from CTD
GO IDGO nameInteraction typeReference
GO:0006874 Cellular calcium ion homeostasis Affects phenotype PMID:24599297
GO:0006915 Apoptotic process Increases phenotype PMID:29601929
GO:0006974 Cellular response to dna damage stimulus Affects phenotype PMID:27589474; PMID:29601929
GO:0008283 Cell population proliferation Increases phenotype PMID:26988655
GO:0032469 Endoplasmic reticulum calcium ion homeostasis Affects phenotype PMID:24599297
GO:0045930 Negative regulation of mitotic cell cycle Increases phenotype PMID:29601929
GO:0051348 Negative regulation of transferase activity Affects phenotype PMID:29331935
GO:0051480 Regulation of cytosolic calcium ion concentration Affects phenotype PMID:24599297
GO:0051881 Regulation of mitochondrial membrane potential Affects phenotype PMID:29601929
GO:0051923 Sulfation Decreases phenotype PMID:29331935
GO:0055074 Calcium ion homeostasis Affects phenotype PMID:30056177
GO:0098703 Calcium ion import across plasma membrane Increases phenotype PMID:24599297
GO:1903409 Reactive oxygen species biosynthetic process Increases phenotype PMID:29601929

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.